Clinical Trial Update: Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of Ergoferon in liquid form for acute upper respiratory tract infections completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Ergoferon

Snippet

Sponsor: Materia Medica Holding | Conditions: Acute Upper Respiratory Tract Infections | Phase 3 | Status: COMPLETED | Results posted: 2020-12-11